Some of the world’s largest pharma firms have set out what therapeutic areas and specific mechanisms are becoming more important to them, and which will be left by the wayside and we have the inside scoop. Click here to read Big Pharma’s Wish List
Read More »Diabetes In Control
Diabetics Have a 75% B1 Deficiency Leading to Vascular Problems
A thiamine (Vitamin B1) deficiency may be key to vascular problems for diabetic patients. FDA panel says Avandia offers benefits to people with type 2 disease, but…..
Read More »Statins Safe and Effective for Children With Familial Hypercholesterolemia
Statin therapy is safe and effective for children with heterozygous familial hypercholesterolemia (HeFH), according to new findings.
Read More »Don’t Rely on Beta-Blockers to Reduce Blood Pressure
Research favors other drugs to control hypertension. While high blood pressure patients taking beta-blockers have a reduced risk of stroke of 16 percent to 22 percent compared with a placebo, the other hypertension drugs reduce that risk by an average of 38 percent.
Read More »Postprandial Hyperglycemia’s Related To Abnormal Variations In Blood Pressure
The researchers concluded that abnormal variations in blood pressure were associated with postprandial hyperglycemia, but not fasting hyperglycemia.
Read More »New Onset Diabetes More Likely With Metoprolol Than With Carvedilol in Heart Failure
New onset diabetes in patients with chronic heart failure is more likely to develop with metoprolol than with carvedilol, according to new findings
Read More »American Women Are Getting Fatter By At Least 20 Pounds
You are not the only one! It has become more socially acceptable for women to carry a few extra pounds, according to a new study. The weight of the average woman increased by 20 pounds, or 13.5 percent, during the period of 1976 to 2000.
Read More »Metabolic Syndrome In Kids Increases Adult Heart Risk
Adults who had so-called metabolic syndrome when they were children have a substantially increased risk of having heart disease in their 30s, researchers report.
Read More »Bone Cells May Be Key to Controlling Diabetes- New Possible Treatment
Researchers at Columbia University in New York have discovered that certain bone cells produce a hormone called osteocalcin, which influences beta-cell proliferation and controls the metabolism of blood sugar (glucose) and fat deposits through previously unknown mechanisms.
Read More »Reducing Inflammation Plays Key Role in Type 1 Diabetes Therapy
Researchers at Beth Israel Deaconess Medical Center (BIDMC) have found that a triple combination therapy consisting of both tolerance-inducing and anti-inflammatory properties is successful in abolishing adverse autoimmunity against insulin-producing cells in a mouse model of Type 1 diabetes.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.